Sep 2017 $62 M No. 4 $50 to $250 million 51
Micell Technologies Inc.: Raise no. 4, Sep 2017 × Investors in this round 51 investors had bought by the notice of Sep 19, 2017: 51 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $62 M of $70 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $28,040
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Arthur J. Benvenuto · Executive Officer, Director Timothy G. McMahon · Executive Officer Archibald J. Cox · Director John G. Lowry · Director Kenneth G. Langone · Director Michael G. Stansky · Director Robert S. Langer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Invemed Associates LLC (CRD 6728) · New York, New York Sold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV Signed by Timothy McMahon, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 19, 2017. Read the notice at the SEC .
equity, debt SEC Jun 2017 $42 M No. 3 $10 to $50 million 51
Micell Technologies Inc.: Raise no. 3, Jun 2017 × Investors in this round 51 investors had bought by the notice of Jun 21, 2017: 51 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $42 M of $50 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $28,040
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Arthur J. Benvenuto · Executive Officer, Director Timothy G. McMahon · Executive Officer Archibald J. Cox · Director John G. Lowry · Director Kenneth G. Langone · Director Michael G. Stansky · Director Robert S. Langer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Invemed Associates LLC (CRD 6728) · New York, New York Sold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV Signed by Arthur J. Benvenuto, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 21, 2017. Read the notice at the SEC .
equity, debt SEC Mar 2017 $32 M No. 2 $10 to $50 million 51
Micell Technologies Inc.: Raise no. 2, Mar 2017 × Investors in this round 51 investors had bought by the notice of Apr 4, 2017: 51 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $32 M of $35 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $28,040
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Arthur J. Benvenuto · Executive Officer, Director Daniel G. Estay · Executive Officer, Director Archibald J. Cox · Director John G. Lowry · Director Kenneth G. Langone · Director Michael G. Stansky · Director Robert S. Langer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Invemed Associates LLC (CRD 6728) · New York, New York Sold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV Signed by Arthur J. Benvenuto, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 4, 2017. Read the notice at the SEC .
equity, debt SEC Jun 2016 $26 M No. 1 $10 to $50 million 51
Micell Technologies Inc.: Raise no. 1, Jun 2016 × Investors in this round 51 investors had bought by the notice of Nov 18, 2016: 51 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $26 M of $30 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, other: Offer and sale of Preferred Return Notes, and the underlying shares of Preferred Stock and Common Stock issuable upon conversion thereof. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $28,040
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Arthur J. Benvenuto · Executive Officer, Director Daniel G. Estay · Executive Officer, Director James A. Klein · Executive Officer Archibald A. Cox · Director John G. Lowry · Director Kenneth G. Langone · Director Michael G. Stansky · Director Robert S. Langer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Invemed Associates LLC (CRD 6728) · New York, New York Sold in AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NH, NJ, NM, NV, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV Signed by Arthur J. Benvenuto, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 18, 2016. Read the notice at the SEC .
equity, debt SEC